Dr Jas Sanghera, Co-founder and se­nior part­ner, TTP Group; Chair­man of TTP Labtech

BioSpectrum (India) - - BIO CONTENT - Dr Jas Sanghera, Co-founder and se­nior part­ner, TTP Group; Chair­man of TTP Labtech

“In­dian ini­tia­tives driv­ing growth in trans­la­tional re­search and biobank­ing are com­ple­men­tary to our com­pany ethos”

TTP Labtech, an em­ployee-owned, global leader in the de­sign and de­vel­op­ment of au­to­mated in­stru­men­ta­tion and con­sum­ables for life science ap­pli­ca­tions, based near Cam­bridge, UK has been sup­ply­ing prod­ucts to the Life Science in­dus­try in In­dia for nearly 15 years.

TTP Labtech In­dia is now es­tab­lish­ing a strong foothold in the ge­nomic and sam­ple man­age­ment mar­kets, in­clud­ing biobank­ing. The com­pany is help­ing to de­velop and nur­ture these mar­kets in In­dia and have al­ready in­stalled sev­eral ark­tic and com­POUND units within the area of biobank­ing. Dr Jas Sanghera, Co-founder and Chair­man of TTP Labtech In­dia got in touch with BioSpec­trum to share some of his plans. Edited Ex­cerpts;

Tell us about TTP Labtech In­dia jour­ney so far?

TTP Labtech has been sell­ing prod­ucts into the Life Science mar­ket for 17 years. Over this pe­riod, In­dia has seen sig­nif­i­cant in­vest­ment into this sec­tor from both pri­vate and gov­ern­ment sources whilst the global im­pact of In­dian re­search has been in­creas­ing.

In recog­ni­tion, TTP Labtech opened an of­fice in In­dia, Farid­abad (Delhi-NCR) in 2015 pro­vid­ing sales, en­gi­neer­ing and ap­pli­ca­tion sup­port, com­pli­mented by a Pan In­dian net­work of dis­trib­u­tors and a satel­lite of­fice in Ben­galuru.

Since 2015, TTP Labtech In­dia has de­vel­oped a wealth of tech­ni­cal ex­per­tise within the struc­tural bi­ol­ogy, sam­ple man­age­ment and biobank­ing mar­kets. By en­gag­ing with se­lect man­u­fac­tur­ers in these ar­eas we have been able to sup­ple­ment our port­fo­lio with com­ple­men­tary, in­clud­ing con­sum­ables and soft­ware, to of­fer a com­pre­hen­sive col­lec­tion of mar­ket lead­ing prod­ucts. Our aim is to make the cus­tomers buy­ing ex­pe­ri­ence seam­less through pro­vid­ing a com­plete so­lu­tion.

Which of your prod­ucts are dom­i­nat­ing the Life Sciences In­dus­try in In­dia?

The au­to­ma­tion of protein crys­tal­log­ra­phy screen­ing has made a sig­nif­i­cant con­tri­bu­tion to the rapid ex­pan­sion of crys­tal­log­ra­phy-based struc­tural bi­ol­ogy. Ob­tain­ing crys­tals of a high enough res­o­lu­tion for X-ray dif­frac­tion stud­ies can be a time and cost in­ten­sive process, as an ex­ten­sive num­ber of screen­ing and op­ti­miza­tion ex­per­i­ments need to be car­ried out in or­der to de­ter­mine ideal con­di­tions for crys­tal growth.

Our mos­quito protein crys­tal­log­ra­phy liq­uid han­dling range has been widely adopted within In­dia, the most pop­u­lar prod­ucts be­ing mos­quito xtal, mos­quito LCP and dragon­fly crys­tal. In­ter­est­ingly, this cor­re­lates with global trends where the for­mer two in­stru­ments are con­sid­ered mar­ket lead­ing.

What ad­van­tage does In­dia pro­vide for your protein crys­tal­log­ra­phy prod­ucts?

In­dia has sup­ported crys­tal­log­ra­phy re­search from the 1930’s, al­though it was in 1950’s when GN Ra­machan­dran was named as a found­ing fa­ther of struc­tural bi­ol­ogy. GN Ra­machan­dran was an In­dian physi­cist best known for his de­vel­op­ment of the Ra­machan­dran plot for val­i­dat­ing protein struc­tures but he was also the first per­son to pro­pose a triple­he­li­cal model for the struc­ture of col­la­gen. Since then, In­dia has gone through tur­bu­lent times but has ex­celled in bioin­for­mat­ics. Thanks to the gen­er­ous sup­port from a few in­di­vid­u­als, fund­ing from the Depart­ment of Science and Tech­nol­ogy (DST) and other agen­cies; crys­tal­lo­graphic re­search is on par with lead­ing re­search lab­o­ra­to­ries in the rest of the world. In emerg­ing ar­eas, In­dia has es­tab­lished it­self among the top pub­lish­ing coun­tries.

Our lead­er­ship po­si­tion within this mar­ket re­sults from of­fer­ing a ro­bust port­fo­lio of so­lu­tions­based prod­ucts, cou­pled with first rate ser­vice and ap­pli­ca­tion sup­port.

What are some of the up­com­ing steps for TTP Labtech in In­dia this year?

With a his­tory of in­no­va­tion and be­ing at the fore­front of new tech­nol­ogy in­tro­duc­tion, TTP Labtech has be­come an in­dus­try leader within the ar­eas of biobank­ing and nano­litre liq­uid han­dling ap­pli­ca­tions, the lat­ter of which in­cludes; protein crys­tal­log­ra­phy and more re­cently ge­nomics

(NGS, sin­gle cell se­quenc­ing and high-through­put tran­scrip­tomics).

To show­case our so­lu­tions within these ap­pli­ca­tions, we will be par­tic­i­pat­ing in a plethora of ma­jor global con­fer­ences, such as AGBT (Ad­vances in Genome Bi­ol­ogy and Tech­nol­ogy), where we will be pro­mot­ing our mos­quito range of liq­uid han­dlers for minia­turised ge­nomics ap­pli­ca­tions. Here we plan to speak to re­searchers about minia­tur­is­ing their

NGS (Next-Gen­er­a­tion Se­quenc­ing), sin­gle cell and tran­scrip­tomics work­flows.

Within sam­ple man­age­ment this year, TTP Labtech will proudly in­stall an ark­tic biobank­ing sys­tem into a lead­ing In­dian In­sti­tute and a com­POUND into a pri­vate com­pany for chem­i­cal li­brary stor­age, both of which will strengthen our foothold in In­dia and help to pro­vide a solid foun­da­tion for fu­ture growth.

What new sci­en­tific ar­eas is TTP Labtech ex­plor­ing in the com­ing years for strength­en­ing its foothold in In­dia, and why?

One of the pri­mary rea­sons for es­tab­lish­ing our In­dian en­tity, was to nur­ture and sup­port the growth of new ini­tia­tives in In­dia. Short term within In­dia, we an­tic­i­pate sig­nif­i­cant growth op­por­tu­ni­ties within the ap­pli­ca­tion ar­eas men­tioned above, how­ever, look­ing to the fu­ture, we ob­serve in­creased mar­ket in­ter­est in emerg­ing tech­nolo­gies such as cryo-elec­tron mi­croscopy (Cry­oEM). To fur­ther strengthen our foothold within the struc­tural bi­ol­ogy mar­ket, we are de­vel­op­ing novel so­lu­tions that ad­dress cur­rent sam­ple prepa­ra­tion bot­tle­necks with the aim of im­prov­ing Cry­oEM pro­duc­tiv­ity.

What are the main chal­lenges the In­dian Life Sciences In­dus­try is fac­ing to­day?

In­dia is one of the fastest grow­ing economies in the world, how­ever, his­tor­i­cally we have seen a lag in the adop­tion of new tech­nolo­gies and in­no­va­tions in In­dia. To truly com­pete on the global stage, this is some­thing In­dia needs to ad­dress.

What more can the ex­ist­ing In­dian ecosys­tem of­fer the Life Sciences In­dus­try for mak­ing it a leader?

Be­com­ing a key global leader within Life Sciences will re­quire sig­nif­i­cant R&D in­vest­ment from both the In­dian Gov­ern­ment and pri­vate sec­tors, in con­junc­tion with po­lices that sup­port and pro­mote in­no­va­tion. Sev­eral ini­tia­tives de­signed to drive growth through in­no­va­tion are be­ing im­ple­mented within Life Science, in­clud­ing the trans­la­tional re­search and biobank­ing mar­kets. To en­sure their suc­cess, it is im­per­a­tive that such ini­tia­tives are im­ple­mented quickly and backedup by a sta­ble cash-flow.

Why is TTP Labtech com­mit­ted to sup­port­ing growth in the life science re­search mar­ket in In­dia?

In­dian ini­tia­tives driv­ing growth in trans­la­tional re­search and biobank­ing are com­ple­men­tary to our com­pany ethos. We de­sign and man­u­fac­ture ro­bust, re­li­able and easy-to-use so­lu­tions for life science re­search. En­abling life sci­en­tists through col­lab­o­ra­tion, deep ap­pli­ca­tion knowl­edge and lead­ing en­gi­neer­ing to ac­cel­er­ate re­search and make a dif­fer­ence to­gether. Many of our in­no­va­tions have been born out of the de­sire to cre­ate so­lu­tions to ex­ist­ing cus­tomer prob­lems; and it’s this ethos that drives TTP Labtech’s R&D ef­forts. Our strengths come from the trust our cus­tomers have with us to de­velop truly unique, au­to­mated tech­nolo­gies to meet their needs.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.